Volume 41 Issues 1 and 2


Volume 41 Fall 2009 & Winter 2010 Nos. 1&2

Articles
ANTICOMPETITIVE PRODUCT CHANGES IN THE PHARMACEUTICAL INDUSTRY Steve D. Shadowen, Keith B. Leffler & Joseph T. Lukens 1
solving the drug settlement problem: the legislative approach Michael A. Carrier 83
walker process proof: the proper prescription B.D. Daniel 105
predominance of common questions—common mistakes in applying the class action standard J. Douglas Richards & Benjamin D. Brown 163
when caught with your hand in the cookie jar . . . argue standing Jay L. Himes 187
WHERE DO WE GO NOW? THE HATCH–WAXMAN ACT TWENTY-FIVE YEARS LATER: SUCCESSES, FAILURES, AND PRESCRIPTIONS FOR THE FUTURE Linda P. Nussbaum & John D. Radice 229
APPLYING LITIGATION ECONOMICS TO PATENT SETTLEMENTS: WHY REVERSE PAYMENTS SHOULD BE PER SE ILLEGAL Joshua P. Davis 255
BUCKMAN STOPS HERE! LIMITS ON PREEMPTION OF STATE TORT CLAIMS INVOLVING ALLEGATIONS OF FRAUD ON THE PTO OR THE FDA Louis M. Bograd & Andre M. Mura 309
OF VULNERABLE MONOPOLISTS: QUESTIONABLE INNOVATION IN THE STANDARD FOR CLASS CERTIFICATION IN ANTITRUST CASES Joshua P. Davis & Eric L. Cramer 355
UNKNOWING THIEVES: REFORMING THE LEGAL LINK BETWEEN IMMIGRATION AND IDENTITY THEFT John P. Wixted 403
OVERCROWDED PRISONS AND FILIAL RESPONSIBILITY: WILL STATES UTILIZE “SUPPORT OF THE INDIGENT” STATUTES TO SOLVE THE BABY BOOMER AND PRISON CRISES? Lynda Yamamoto 435
R.A.P.: RULE AGAINST PERPS (WHO WRITE RHYMES) Jason E. Powell 479